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Joint Paper
Tackling the 21st century’s foremost health threat
This document calls on the European Union (EU) Institutions, 
especially the European Commission, to advance firm action 
on non-communicable diseases (NCDs) by estab lishing an EU 
Strategic Framework for the Prevention of NCDs towards 2030. 
It sets out basic principles, priorities and actions to 
maximise EU’s added value in tackling one of the 21st 
century’s foremost threats to health and well-being.
With epidemic levels of chronic diseases undermining 
people’s well-being, healthcare systems, and Europe’s 
economic and social prosperity, preventing NCDs should 
be a main priority for the European Commission.
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Action 1: Support the implementation of WHO ‘Best Buys’
DELIVERABLES: 
 > A set of technical toolkits setting out different design options for the national implementation of each of the 
policy measures included in the WHO ‘best buys’, tailored to the EU context.
 > A list of ‘impact indicators’ that Member States can use to support progress monitoring. 
 > A mechanism for periodically analysing gaps in NCD policy at EU level and initiating legislative procedures 
where needed, possible and appropriate. 
 > A risk assessment on the occurrence of conflicts of interest across EU institutions and an action plan with 
measures to prevent undue influence by vested interests over policy-making processes. 
Action 2: Conduct a ‘health check’ study to identify EU barriers to the 
implementation of national NCD prevention policies
DELIVERABLES: 
 > A comprehensive legal ‘health check’ inventory of EU and international barriers to the implementation of 
effective NCD prevention policies at national and local levels. 
 > An action plan to alleviate these barriers or guidance for designing national NCD prevention policies in a way 
to enhance their chance to be upheld under legal scrutiny. 
Action 3: Design EU financial instruments to support national investment 
in prevention programmes and measures
DELIVERABLES: 
 > A cross-sectoral expert group on Financing for Health, which will assess and propose different options to 
enhance societal returns on investment by increasing programmes to fund NCD prevention.
Action 4:  Elaborate a pan-European system for data collection, policy 
evaluation and accountability
DELIVERABLES: 
 > An EU-wide system for health data collection and information sharing containing registries for key NCD 
indicators. 
 > An extensive study putting forward methodologies for new health policy evaluation tools. 
 > A process of ‘shadow reporting’ where civil society can contribute with their assessments on the progress 
made towards fulfilling NCD-related commitments. 
 > An assessment of how health systems can better address primary prevention. 
 > An evaluation of the added value of past research funding and possible a proposal for ex-ante conditionalities 
in the area of health-relevant projects and funding. 
Action 5: Ensure inter-institutional coordination on health and well-being 
and a policy home for health within the European Commission structure
DELIVERABLES: 
 > A new EU high-level coordination mandate, such as a European Commission vice-president, that will ensure 
inter- and intra-in stitutional policy coordination for health and well-being.
Action 6: Launch a ‘Health in All Policies’ online policy portal
DELIVERABLES: 
 > A ‘Health in All Policies’ online policy portal, which should: 
 > Present an overview of ongoing, health relevant initiatives in all policy areas; 
 > Publish the results of all health impact assessments and provide the opportunity for continuous 
improvements in methodology; 
 > Monitor national implementation of health-related policies to promote better compliance with EU health-
related policies;
 > An updated methodology for health impact assessment and a process for regular updates to the 
methodology. 
 > An analysis of compliance with a select number of key policy files, in particular those related to the national 
implementation of policies focused on children and youth.
Action 7:  Pursue ‘EU flagship initiatives’ in areas that can deliver co-ben-
efits for NCD prevention and other SDGs
DELIVERABLES: 
 > A series of action plans to pursue EU ‘flagship initiatives’ in areas where clear co-benefits can be achieved 
between NCD prevention and other policy areas.
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European collaboration and action in the field of public health. 
EU-wide action offers significant opportunities to deliver added 
value to citizens 14/, which is indispensable for rebuilding trust in 
the Union’s ability to act where it matters.
This document calls on the EU Institutions, and in particular the 
European Commission, to advance firm action on NCDs by estab-
lishing an EU Strategic Framework for the Prevention of NCDs 
towards 2030 early in its 2019-2024 mandate. The overarching 
aim of such framework would be to support EU Institutions and 
Member States in responding to citizens’ concerns and achieving 
their international and European commitments, notably the World 
Health Organization (WHO) Global Action Plan for the Prevention 
and Control of NCDs 15/ and the United Nations (UN) Sustainable 
Development Goals (SDGs) 16/. 
In particular, the EU Strategic Framework for the Prevention of 
NCDs should provide a solid base to expand on the EU Strategy 
on Nutrition, Overweight, and Obesity-related health of 2007 17/ 
and the EU Reflection Process on Chronic Diseases 2010-2014 18/. 
Furthermore, it should complement and provide coherence, 
structure and direction to existing instruments and mechanisms, 
including the work of the Steering Group on Health Promotion, 
Disease Prevention and Management of Non-Communicable 
Diseases 19/ and the European Social Fund Plus 20/.
This document sets out a series of basic principles, priorities 
and actions for this future strategic framework. It follows the 
Political Declaration of the Third UN High Level Meeting on NCDs 
of September 2018 21/, in which governments worldwide, as well 
as the EU, strongly reaffirmed their commitment to accelerate 
action on NCD prevention and control, stressing the primary role 
and responsibility of governments acting individually at national 
or local level, or collectively at EU level, in responding to the 
challenge.
Non-communicable diseases matter
Non-communicable diseases (NCDs), or chronic diseases, 
undermine people’s health and well-being, the sustainability 
of healthcare systems, and Europe’s economic and social 
prosperity. Today, approximately one third of the European Union 
(EU) population aged 15 and over 1/, and nearly a quarter of the 
working age population lives with a chronic disease 2/. More than 
half a million people under the age of 65 die of NCDs in the EU 
each year 3/. 
While progress is made on reducing premature mortality from 
NCDs 4/, longer lives do not necessarily translate into healthy 
lives. Too often people live longer but are burdened by one or 
more chronic conditions: a significant gap exists between life 
expectancy and healthy life expectancy. It is estimated that, on 
average, women in the EU spend almost a quarter (23%) of their 
lives in ill health; for men this figure is almost a fifth (19%) 5/. 
Good health is not just the absence of disease, but a state of 
complete physical, mental and social well-being, the attainment 
of which is a basic human right and aspiration 6/. Health and 
social security are the second most important national concerns 
across Europe 7/. Indeed, 70% of the population wants to see more 
EU action on health 8/. Yet the prevalence of chronic diseases has 
been growing in the EU and the wider European region over the 
past decades 9/. People in disadvantaged households are dispro-
portionately affected by NCDs and suffer from a greater share of 
life lived in ill-health 10/.
The EU has a strong mandate to protect and promote people’s 
health and well-being. The Union’s founding Treaties provide that 
the EU’s main aims are to promote “peace”, “its values” and “the 
well-being of its peoples” 11/. The internal market is established 
to work for the “sustainable development of Europe” 12/. The EU 
is furthermore obliged to pursue a high level of health protection 
and promotion in all its policies 13/. Faced with common, European 
health challenges, there is urgent need for more ambitious 
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The economic case for tackling NCDs
NCDs impair the EU’s economic development
Europe’s greatest resources are its people. However, epidemic 
levels of NCDs are undermining this source of prosperity and 
leading to major direct and indirect costs to national budgets 
and the economy 34/. Healthcare is the second largest area of 
public spending by EU Member States, with over €1 trillion, or 
between 7-10% of EU GDP spent by governments annually 35/ 36/. 
€700 billion is spent on treating NCDs in the EU each year 37/. This 
is the same amount as InvestEU intends to mobilise over the 
next 7-year budget period to boost investment, innovation and 
job creation 38/. Premature mortality from NCDs results in a loss 
of €115 billion per year to the economy, or 0.8% of EU GDP 39/. 
The NCD epidemic is a global phenomenon with worldwide 
repercussions. The World Economic Forum and the Harvard 
School of Public Health predicted in 2011 that, in a “business as 
usual” scenario, NCDs would result in a cumulative loss in global 
economic output of $47 trillion, or 5% of GDP, by 2030. 40/ The 
predicted cumulative losses would be significantly larger if the 
economic value and utility that people attribute to health were 
adequately captured.
NCDs significantly affect the labour market, including work 
participation, productivity, hours worked, job turnover, retirement 
and career progression 41/. Absenteeism, presenteeism, and sick 
leave impose a major macroeconomic impact. Work-related 
annual costs of NCDs to the European economy add up to €610 
billion per year, including costs to employers, lost economic 
output and costs to social welfare systems 42/. Overall, 1.7% of 
GDP in the EU is spent on disability and paid sick leave each year, 
which is more than the expenditure on unemployment benefits 43/. 
This while a healthy workforce is essential to support an ageing 
population. 
At the same time, people living with NCDs suffer from reduced 
productivity, reduced employment, earlier retirement, and lower 
income. They face barriers to employment and stigma, with conse-
quences for earnings and prospects for professional growth 44/. 
NCDs also have a substantial impact on the health, quality of life 
and work participation of caregivers. A large number of people 
report acting as a voluntary caregiver for family members with a 
chronic condition, which has limited their own work participation, 
productivity and opportunities for job advancement, and often 
takes a toll on physical and mental health 45/. 
NCDs furthermore impair the participation of older persons in 
society. For instance, many retired people act as caregivers for 
family members, such as grandchildren or their own older parents, 
or engage in volunteering activities 46/ 47/.  Supporting healthy 
ageing across the lifespan is also key to support autonomy and 
independent living among older persons, and thus reducing the 
need for care and support 48/.
The cost saving potential of NCD prevention
A significant proportion of the direct and indirect costs of NCDs 
in Europe could be saved through preventative policies and 
actions 49/. For instance, the WHO estimates that at least 80% of 
all heart disease, stroke and diabetes, and 40% of cancer could be 
prevented. 50/ Improving public health could dramatically reduce 
national social protection bills, which currently account for over 
19% of public spending in the EU 51/. Tackling health inequalities 
would also bring major economic benefits for public finances, as 
these have been calculated to account for one-fifth of the total 
cost of healthcare and 15% of the total costs of social security 
benefits. 52/
What are non-communicable 
or chronic diseases?
Non-communicable diseases (NCDs), also known as chronic 
diseases, encompass a wide variety of physical and mental 
medical conditions that are not caused by infectious agents. 
According to the WHO, NCDs “tend to be of long duration 
and are the result of a combination of genetic, physiological, 
environmental and behavioural factors” 22/. 
Cardiovascular diseases (CVD), diabetes, cancers, chronic 
respiratory diseases 23/ and more recently also mental 
disorders, are considered the five ‘major’ NCDs 24/. Yet many 
more types of NCDs are affecting Europeans, including liver, 
endocrine and musculoskeletal diseases and disorders 25/. 
Obesity is a ‘gateway’ to many NCDs and has been recognised 
as a chronic disease in its own right in some countries, but 
not all 26/ 27/. 
NCDs are the major health issue of the 21st century. Over 85% 
of all deaths and 75% of all diseases in Europe are attributable 
to NCDs 28/.
A number of themes are shared across the range of NCDs:
• Chronicity: many chronic diseases develop over time in 
response to a prolonged exposure to risk factors. Chronicity 
also refers to the long-lasting or recurring nature of a disease 
or condition. NCDs are however not necessarily irreversible, 
as for instance shown by recovery-based approaches to 
mental health. Common risk factors: in addition to genetic 
determinants, the vast majority of NCDs share a limited 
number of common, modifiable risk factors. The five main 
NCD risk factors are: tobacco use, harmful levels of alcohol 
consumption, unhealthy diets, low physical activity and 
exposure to environmental contaminants, foremost air 
pollution. 
Economic activities, or ‘commercial determinants’ (see 
below), influence to a large extent the level of impact of these 
main risk factors. Tobacco, food and alcohol are marketed 
products. Exposure to outdoor air pollution is driven by 
exhausts from vehicles, energy generation, industrial activities 
and agriculture. Sedentary lifestyles are influenced by many 
factors including screen time, the urban and transport environ-
ments and the wider socio-economic employment context. 
Mental health disorders are associated with an even wider 
range of risk factors 29/.
• Socio-economic inequalities: NCDs are driven and exacer-
bated by socio-economic inequalities and are closely 
associated with poverty and underdevelopment. People in 
lower socio-economic groups consistently show a higher 
incidence of NCDs and are more strongly impacted by 
them 30/ 31/.
• High degree of preventability: Many NCDs are preventable 
to a considerable degree, or their onset can be delayed. The 
WHO estimates that at least 80% of all heart disease, stroke 
and diabetes, and 40% of cancer cases could be prevented if 
the main risk factors for NCDs were addressed 32/.
• Prevalence of multimorbidity: Multimorbidity is the co-oc-
currence of chronic conditions and is the norm for people 
living with NCDs 33/. The drivers of multimorbidity are poorly 
understood, but research is advancing on why certain condi-
tions cluster together and what effective prevention and 
management strategies can be adopted. 
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Public health prevention policies offer a targeted and cost-ef-
fective way to improve the health and well-being of Europeans 
through the creation of health-enabling environments. Such 
interventions not only offer a significant cost saving potential 
to strained budgets across the EU, but are a high-yielding public 
investment. A recent meta-study shows that the median rate 
of return on investment for public health interventions is 1 to 
14, meaning that every Euro invested in public health gives an 
average return of €14 to the economy 53/. Despite this, less than 
3% of health expenses today are invested in prevention 54/.  
Three stages of prevention
Primary prevention aims to prevent diseases before they 
occur. Primary prevention is the ‘purest’ form of prevention 
and the primary focus of this document. Tobacco use, 
harmful levels of alcohol consumption, unhealthy diets with 
high intakes of fats, sugars and salt, low physical activity and 
air pollution are the five primary risk factors responsible for 
the main burden of NCDs. Primary prevention policies aim to 
create living environments that are conducive to good health 
and well-being and that minimise the prevalence of these risk 
factors. Such policies create the contexts that enable and 
empower people to select healthier options, and to prevent 
exposure to health-harming influences beyond individual 
control.
Examples include: the WHO Framework Convention on 
Tobacco Control (FCTC) which promotes a comprehensive 
set of measures targeting both demand and supply of tobacco 
products; pricing policies which are among the most effective 
NCD prevention measures 55/; regulations that limit the 
exposure of youth to the advertising of alcoholic beverages 
and unhealthy food products; legislation setting limits to trans 
fats in food; physical activity-friendly urban planning policies; 
and pollution limits for vehicles. 
Secondary prevention aims to reduce the impact of a disease 
or injury after it occurs. Secondary prevention is about 
detecting and treating disease or injury as soon as possible 
to halt or slow its progress. It is about managing patients, 
encouraging personal strategies to prevent recurrence, and 
implementing programs to return people to their original state 
of health and functionality in order to prevent long-term health 
issues. 
Examples include: screening tests to detect and treat disease 
in its earliest stages (e.g. mammograms to detect breast 
cancer); diet and exercise programs to prevent further heart 
attacks or strokes as well as overweight or obesity; work 
modifications that allow injured or ill workers to return safely 
to their jobs.
Tertiary prevention aims to soften the impact of an ongoing 
illness or injury that has lasting effects. This is done by helping 
people manage long-term, often-complex health problems 
and injuries, such as NCDs, in order to improve as much as 
possible their ability to function, their quality of life and life 
expectancy. 
Examples include: cardiac or stroke rehabilitation programs; 
prevention of relapse or metastatic disease for cancer; NCD 
management programs (e.g. for diabetes, arthritis, and 
depression); support groups; and vocational rehabilitation 
programs.
For prevention to succeed, effective and well-funded healthcare 
systems are required to which all people have equitable 
access and which are delivered by a skilled, well-staffed health 
workforce. Health professionals with appropriate training in 
primary prevention can provide a major contribution to the 
NCD prevention agenda given their direct contact with people 
in a wide variety of settings. Primary, secondary and tertiary 
prevention also cover workplace settings, where organisa-
tional change and occupational health measures can prevent 
or reduce the impact of both physical and mental illnesses, 
including stress and musculoskeletal diseases 56/ 57/.  
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2. A Strategy 
that Builds 
on Existing 
Initiatives
The future EU Strategic Framework for the Prevention of NCDs 
should not reinvent the wheel, but rather should build on the 
extensive work already done by numerous institutions and 
civil society organisations at global, European, national and 
local levels. As a primary objective it should contribute to the 
effective implementation of already existing NCD prevention 
commitments. While doing so, it should raise the bar and attain 
a higher level of effectiveness and ambition in preventing NCDs 
across the EU.
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support Member States in achieving the commitments made 
therein. In particular, the EU Strategic Framework should be 
guided by the same overarching principles as adopted under the 
action plan, which are summarised below.
Life-course approach: NCD prevention strategies should take 
account of the health and social needs at all stages of the life 
course, starting with maternal health, continuing through proper 
infant feeding practices, health promotion for children, adoles-
cents and youth, followed by promotion of a healthy working life, 
healthy ageing and care for people with NCDs diseases in later 
life. Particular attention is required for the ‘first 1000 days of 
life’, roughly the period between conception and a child’s second 
birthday, a foundational period for future health and well-being 60/.
Evidence-based strategies: NCD prevention strategies should 
be based on latest scientific evidence, be cost-effective and 
affordable, and based on public health principles.
Human rights approach: NCD prevention strategies should 
take the fundamental right of every human being to the highest 
attainable standard of health as a starting point for all activities.
Equity-based approach: NCD prevention strategies should 
recognise that the unequal distribution of NCDs is closely linked 
to the inequitable distribution of social determinants of health, 
and that action on these determinants should be an integral part 
of the NCD response.
Universal health coverage: NCD prevention strategies should 
ensure that all people have access to nationally determined sets 
of the needed promotive, preventive, curative and rehabilitative 
basic health services and essential, safe, affordable, effective 
and quality medicines.
Empowerment of people and communities: NCD prevention 
strategies should involve and empower people, communities and 
health professionals to engage in prevention activities, including 
in advocacy, policy, planning, legislation, service provision, 
monitoring, research and evaluation.
National action and international cooperation and solidarity: the 
primary role and responsibility of governments in responding 
to the challenge of NCDs by implementing effective prevention 
strategies should be recognised, together with the importance of 
international cooperation.
Multi-sectoral action: NCD prevention strategies require strong 
leadership and coordinated multi-sectoral engagement for 
health, such as through the ‘health in all policies’ and ‘whole-of-
government’ approaches.
Management of real, perceived or potential conflicts of interest: 
NCD prevention strategies should be protected from undue 
influence by any form of vested interest, in particular when 
engaged in multi-stakeholder approaches. Real, perceived or 
potential conflicts of interest must be acknowledged, prevented 
and managed. Private sector actors have a role to play in policy 
implementation, but policy decisions and policy design must be 
free from influence of (potentially) health-incompatible vested 
interests.
The WHO Global Action Plan on NCDs
The WHO Global Action Plan for the Prevention and Control of 
NCDs envisions a world “free of the avoidable burden of noncom-
municable diseases” 58/ and sets out nine voluntary global NCD 
reduction targets to be achieved by 2025 59/. Unanimously 
adopted by WHO member states, it is the main reference work 
for action on NCDs worldwide. 
Nine voluntary global targets
Target 1: A 25% relative reduction in the overall mortality from 
cardiovascular diseases, cancer, diabetes, or chronic respi-
ratory diseases.
Target 2: At least 10% relative reduction in the harmful use of 
alcohol, as appropriate, within the national context.
Target 3: A 10% relative reduction in prevalence of insufficient 
physical activity.
Target 4: A 30% relative reduction in mean population intake 
of salt/sodium.
Target 5: A 30% relative reduction in prevalence of current 
tobacco use in persons aged 15+ years.
Target 6: A 25% relative reduction in the prevalence of raised 
blood pressure or contain the prevalence of raised blood 
pressure, according to national circumstances.
Target 7: Halt the rise in diabetes and obesity.
Target 8: At least 50% of eligible people receive drug therapy 
and counselling (including glycaemic control) to prevent heart 
attacks and strokes. 
Target 9: An 80% availability of the affordable basic technol-
ogies and essential medicines, including generics, required to 
treat major NCDs in both public and private facilities. 
The future EU Strategic Framework for the Prevention of NCDs 
should explicitly refer to the WHO action plan and undertake to 
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Ongoing EU processes
 The EU chronic disease reflection process 2010-2014
In response to the 2010 EU Council Conclusions on chronic 
diseases 74/, the European Commission launched a reflection 
process to identify options for optimising the response to 
NCDs. This reflection process resulted in a report identifying 
two main priority areas for EU action: (1) prevention and health 
promotion, and (2) disease management, with an emphasis on 
patient empowerment 75/. It also recognised that Europe should 
be steering the response to chronic diseases. 
The final report from the reflection process was endorsed by the 
EU Council Working Party on Public Health in 2013, committing to 
the continuation of actions on specific diseases and risk factors. 
This was followed by a major EU chronic disease summit in April 
2014 76/. The latter did not, however, result in any significant and 
specific political commitments.
The European Commission’s 2016 ‘new approach’
In 2016 the European Commission recognised that, with current 
actions, only two of the nine WHO global NCD targets would 
be met by 2025, and presented a so-called ‘new approach’ to 
NCDs at a meeting of relevant interest groups 77/. Under this ‘new 
approach’ the European Commission dismantled various expert 
groups, including those on cancer, dementia, rare diseases, 
health and social inequalities, and established a Steering Group 
on Health Promotion, Disease Prevention and Management of 
Non-Communicable Diseases 78/. This Steering Group was set 
up to advise the European Commission on the development and 
implementation of NCD-related activities, and to foster exchanges 
of relevant experience, policies and practices between Member 
States. The Steering Group became a formal expert group of the 
European Commission in July 2018 with its membership limited 
to government representatives.
The European Commission also set up the “EU Health Policy 
Platform” for civil society organisations and other non-gov-
ernmental interest groups. This online forum aims to enable 
health-related discussions and facilitate joint statements 
between various organisations 79/. The platform however lacks 
a meaningful link to policy decision-making processes, raising 
questions about its effectiveness and policy relevance.
Agenda 2030 and the European Social Fund Plus
In September 2015, the European Union and all Member States 
adopted the UN Sustainable Development Goals (SDGs) and 
committed to their implementation into national and European 
policy. In 2017, the EU General Affairs Council called on the 
European Commission to define an SDG implementation 
strategy 80/. The EU Multi-Stakeholder Platform on SDGs, estab-
lished to consult the European Commission on its SDG agenda, 
produced an input document to this strategy, which included 
focus on the prevention and control of NCDs 81/. In January 
2019 the European Commission published its reflection paper 
“Towards a sustainable Europe by 2030”, including reference to 
the NCD agenda and a strong commitment to develop coherent, 
cross-cutting policy approaches 82/.
Another major development is the merging of the EU Health 
Programme, the EU’s main funding mechanism for action on 
health, into the “European Social Fund Plus” (ESF+). The reper-
cussions of this merger, which will be implemented as part of the 
EU budget cycle 2021-2027, remain unclear at the time of writing, 
but could signal a closer integration between health and social 
policies. 
Other key international and 
European commitments
Countries worldwide, including all EU member states, have 
adopted different commitments explicitly intended to prevent 
and control NCDs. These include commitments in the framework 
of the WHO (see above), the three United Nations (UN) High Level 
Meetings on NCDs held between 2011 and 2018 61/ 62/ 63/ and those 
linked to the adoption of the Sustainable Development Goals 
(SDGs)  64/. Important commitments have also been made in the 
context of the WHO Regional Office for Europe and the EU. 
Yet states’ duties to tackle NCDs and improve people’s health 
and well-being go beyond the commitments made in specifically 
dedicated political fora. These duties are ingrained in interna-
tional human rights law, which recognises individuals as rights 
holders and states as duty bearers, and which defines a range of 
universal and inalienable rights that states have a duty to protect, 
respect and fulfil, including the right to the enjoyment of the 
highest attainable standard of health 65/.
Spotlight: main international and 
European commitments on NCDs
Global
Political Declaration of the High-level Meeting of the General 
Assembly on the Prevention and Control of Non-Communi-
cable Diseases 66/
WHO Global Monitoring Framework on NCDs with 9 voluntary 
targets on NCDs for 2025 67/
WHO Global action plan for the prevention and control of 
NCDs 2013-2020 68/
Outcome Document of the 2nd UN High Level Meeting on 
NCDs in 2014 69/
Outcome Document of the 3rd UN High Level Meeting on 
NCDs in 2018 70/
Sustainable Development Goals (SDGs), especially Goal 3: 
Ensure healthy lives and promote well-being for all at all ages 71/
WHO European region 
WHO Action Plan for the Prevention and Control of Noncommu-
nicable Diseases in the WHO European Region 2016–2025 72/
WHO Action Plan for implementation of the European Strategy 
for the Prevention and Control of Noncommunicable Diseases 
2012−2016 73/
In addition to commitments specifically related to chronic 
diseases, a number of risk-factor specific commitments and 
legal obligations exist, including the Framework Convention 
on Tobacco Control and its protocols. 
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Joint actions 
Joint actions are public health programmes carried out by EU 
Member States in collaboration with the European Commission, 
funded by the EU. Joint actions aim to facilitate the exchange 
of best practice, enhance operational capacity to tackle health 
challenges and improve the take-up of health promotion oppor-
tunities.
Key joint actions relevant for tackling NCDs include: 
 > Joint action on Chronic Diseases (JA-CHRODIS) which ran 
between 2014-2017 and was succeeded by joint action 
CHRODIS+ (2017-2020)
 > Joint action on European Partnership for Action Against 
Cancer (JA-EPAAC) 
 > Joint action on Comprehensive Cancer Control (JA-CANCON)
 > Joint action on Innovative Partnership for Action Against 
Cancer (JA-IPAAC)
 > Joint action on Mental Health and Wellbeing
 > Joint action on Tobacco Control (JATC)
 > Joint action on Reducing Alcohol Related Harm (JA-RARHA)
 > Joint action on Nutrition and Physical Activity (JA-NPA)
 > Joint action on Health Workforce Planning and Forecasting
EU powers to prevent NCDs
The question of whether and to what extent the EU can act 
on NCDs is critical for establishing the scope of the future 
EU Strategic Framework for the Prevention of NCDs. Under-
standing EU competence is fundamental in that it circum-
scribes EU intervention and determines its legality in all areas 
of policy-making 83/. 
Article 5(1) of the Treaty on European Union (TEU) provides 
that “the limits of Union competences are governed by the 
principle of conferral”, whereas their use “is governed by 
the principles of subsidiarity and proportionality”. The EU’s 
power to act therefore is subject to the competences it has 
received 84/.
Extensive soft law powers to act for health
In the field of health policy, the EU derives extensive ‘soft law’ 
powers from Article 168 of the Treaty on the Functioning of 
the European Union (TFEU). The EU can provide research 
funding, draw-up guidelines and indicators, establish fora for 
best-practice exchange and debate, adopt non-binding recom-
mendations, promote cooperation with organisations like the 
WHO and so forth. This is uncontroversial.
Duty to mainstream public health in all policies 
By requiring that “a high level of human health protection shall 
be ensured in the definition and implementation of all Union 
policies and activities”, Article 168(1) TFEU acknowledges 
that public health should not be pursued only via earmarked, 
distinct policies, but must be incorporated in all other EU 
policy areas. Such a ‘mainstreaming’ provision is all the more 
relevant in an area like NCD prevention that requires a coordi-
nated, multi-sectoral response.
Article 9 TFEU and Article 35 of the EU Charter of Fundamental 
Rights contain similar obligations. While mainstreaming 
obligations do not extend the competences of the Union, they 
do increase the pressure on the EU to ensure consistency 
between its policies and activities. The EU’s strong regulatory 
powers in the field of internal market, environmental and 
consumer protection, health and safety at work, and agricul-
tural policy and, to a lesser extent taxation, could, and should, 
all be used more effectively to prevent NCDs and promote 
better health for all. 
Limited competence to introduce legislation on a health legal 
basis
While Article 168 TFEU allows the EU to engage in a wide 
range of non-binding, supportive actions and mandates the 
pursuit of a high level of health protection in all EU policies, 
paragraph 5 of the same provision excludes the adoption of 
“any harmonisation of the laws and regulations of the Member 
States”. Consequently, the EU does not have the authority, on 
the basis of this provision, to adopt common EU-wide harmon-
ising legislation for many actions related to the prevention of 
NCDs. 
This limitation has too often been misinterpreted to mean that 
the EU has no powers at all to adopt legally binding measures 
to promote health and prevent diseases. In reality it does. 
However, the EU must rely on a legal basis which allows the 
harmonisation of national laws
Extensive powers to ensure the functioning of the internal 
market with a high level of health protection
Most of the EU legislative measures regulating the markets 
for tobacco, alcohol and unhealthy food – associated with the 
major NCD risk factors – have been adopted on the basis of 
Article 114 TFEU which empowers the EU to adopt legislative 
measures for the establishment and functioning of the internal 
market. 85/ Article 114(3) TFEU mandates the EU to take “as 
a base a high level of protection” of health while proposing 
policy under this provision. 
The Court of Justice of the European Union (ECJ) has delivered 
a range of high profile rulings which delineate the scope of 
EU powers under this provision. In particular, while Article 114 
TFEU cannot be used to circumvent the limitations of Article 
168 TFEU, it can be relied upon as a legal basis for action even 
when public health considerations are “a decisive factor in the 
choices to be made” 86/. 
Article 114 TFEU can be used if three conditions are fulfilled:  
• there must exist an “internal market barrier” resulting from the 
disparities in the legal systems of the Member States;
• this market barrier must not consist of an “abstract risk of 
obstacles”, but should be “such as to obstruct the funda-
mental freedoms” or create “distortions of competition” within 
the internal market; and
• the intended harmonisation should “genuinely have as its 
object the improvement of the conditions for the estab-
lishment and functioning of the internal market”. 87/
The ECJ has interpreted these conditions generously. 88/ 
This leads to the conclusion that there is significant, though 
not unlimited, scope for the EU to regulate for the prevention 
of NCDs, and in particular to address the commercial determi-
nants of health through the adoption of legally binding rules. 89/
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3. Strategic 
Priorities 
The strategic priorities proposed in this document should 
inform the development, implementation, monitoring and evalu-
ation of the future EU Strategic Framework for the Prevention 
of NCDs. These priorities are not exhaustive, but their pursuit 
is necessary to ensure an effective response. In other words, 
they should be at the forefront in all decision-making processes 
involving the prevention of NCDs, as well as those related to 
health promotion and disease prevention more widely.
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B. Implement the WHO ‘Best Buys’
Many evidence-based policies exist to tackle the drivers of NCDs. 
The WHO “Best Buys and other recommended interventions” 
are a collection of the most promising policy types, evaluated 
for cost-effectiveness or recommended on the basis of other 
evidence 99/. The ‘best buys’ provide a list of policy options for 
four key NCD risk factors – smoking, harmful use of alcohol, 
unhealthy diet and low physical activity, and for four disease 
areas – cardiovascular disease, diabetes, cancer and chronic 
respiratory disease. Addressing the four key risk factors will help 
tackle a wide range of other NCDs as well. The recommended 
measures include policies on price, advertising, labelling, 
availability and public awareness and are targeted at creating 
health-enabling environments. The WHO projects that over 1.8 
million lives of people between the ages of 30 and 70 could be 
saved in the EU by 2025 if all ‘best buys’ are implemented 100/.
The ‘best buys’ recommendations have been endorsed by 
countries at successive World Health Assembly (WHA) meetings, 
with the latest update in 2017 101/ and an upcoming update at the 
2019 WHA 102/. For the 2020 WHA, the WHO will propose a further 
expansion of the ‘best buys’ with cost-effective policy options on 
mental health and air quality. However, despite endorsements 
progress on the implementation of these policies has, at best, 
been patchy and often less ambitious than required 103/ 104/. The 
future EU Strategic Framework for the Prevention of NCDs 
should focus on rekindling political leadership and providing 
pathways for an ambitious and comprehensive implementation 
of the types of policies recommended by the WHO ‘best buys’.
A. Create health-enabling environments
The health of individuals is shaped by the contexts – the environ-
ments – within which they live 90/. Overweight, for instance, 
is a predictable outcome of interacting with an obesogenic 
environment 91/. Physical activity-friendly environments, on the 
reverse, enhance physical activity 92/ 93/. Food environments, by 
shaping the availability, accessibility, affordability and attrac-
tiveness of foods, affect people’s consumption decisions and 
eating habits 94/. Living in poverty, for multiple reasons, signifi-
cantly reduces one’s capacity to lead a healthy life 95/. 
At the same time, we share our common natural environment, 
the biosphere, with humans worldwide and other living beings. 
Pollution of the natural world, such as the air, affects everyone 
breathing within a particular area 96/. Other major man-made 
environmental impacts, such as climate change, water and 
soil pollution, depletion of biodiversity and degradation of 
ecosystems are severe threats to human well-being and the 
future of human civilisation 97/  98/. 
Acknowledging the centrality of living environments is an 
important conceptual break from the still-dominant ‘individual 
choice’ narrative which places on individuals the entire responsi-
bility for their health and well-being, and the planet’s future. Not 
only is this ‘free choice’ perspective flawed, it can lead to stigma, 
create a sense of personal failing and result in victim blaming. 
The future EU Strategic Framework for the Prevention of NCDs 
should therefore focus on creating health-enabling environments 
that empower and enable people to make healthy choices, for 
instance by making the healthy and sustainable options the 
easiest, most affordable and default options. It should also align 
closely with strategies to protect and enhance the quality of the 
natural environment.
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C. Address the commercial 
determinants of health
The “commercial determinants of health” can be defined as 
“strategies and approaches used by the private sector to promote 
products and choices that are detrimental to health”  105/. These 
strategies cover activities such as marketing, lobbying, public 
relations and the expansion of supply chains for products 
associated with the main risk factors for NCDs. Overall, 
commercial determinants are closely linked to an economic 
model that prioritises wealth creation over health creation. 
A fresh approach is needed towards the private sector. This 
approach should be based on the realisation that commercial 
determinants are key drivers of NCDs, and that effective policies 
are needed to curb detrimental impacts. At the same time, 
preconditions should be generated for the uptake of ‘pro-health’ 
business models 106/. This fresh approach should furthermore 
draw on the reality that conflicts of interest in policy-making 
do exist and that they negatively affect the adoption of public 
interest policies. While industries do not intentionally set out to 
make people unhealthy, a large body of accumulated evidence 
indicates that vested commercial interests often obstruct efforts 
to create health-enabling environments 107/ 108/ 109/ 110/ 111/.
The future EU Strategic Framework for the Prevention of NCDs 
should effectively address the commercial determinants of 
health, both through the implementation of appropriate policies 
and by improving the policy-making environment itself. This 
includes taking concrete steps to free policy-making processes 
from undue influence by vested commercial interests, which 
will facilitate the introduction of evidence-based public health 
policies and help regain public trust in government 112/.
D. Tackle health inequalities
NCDs are a health challenge closely linked to poverty and 
socio-economic inequalities. Health inequalities are avoidable, 
and therefore unfair, and contribute to the variances in health 
status across different socio-economic groups in society. 
Health inequalities most acutely affect the poorest section of 
the population as well as particular groups facing disadvantage 
and discrimination, including women, recent immigrants and 
refugees, ethnic minorities, homeless people, people suffering 
from alcohol or drug addiction, children, older persons, persons 
with disabilities or mental ill-health, prisoners and sex workers.
Major ‘health divides’ by socio-economic status persist within 
and across countries and regions in the EU 113/ 114/. There is over 20 
years’ difference in healthy life years between leading countries 
and those that fall behind 115/. Opportunities available from birth 
are reflected in life expectancies: for example, the average life 
expectancy of Roma people is between 5 and 20 years lower 
than national averages 116/. For homeless people, the picture is 
the bleakest with homeless women, on average, dying at just 
43 years of age and homeless men at 47 due to multiple health 
disadvantages 117/. Inequalities in healthy life years are even more 
pronounced than inequalities in life expectancy: women and men 
from lower socio-economic groups are more likely to be burdened 
by limiting health conditions 118/. The clearest causes of shorter 
life expectancies and fewer healthy life years are explained by 
differences in income and education 119/.
Despite the EU being one the of the world’s most economically 
developed regions, in 2016, 118 million people lived in house-
holds at risk of poverty or social exclusion, equivalent to nearly 
a quarter of the entire population 120/. The future EU Strategic 
Framework for the Prevention of NCDs should realise the 
synergies involved in pursuing social justice and NCD prevention. 
It should also acknowledge that population-based disease 
prevention measures can have significant positive impacts on 
redressing health inequalities 121/.
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F. Pursue an integrated 
approach to mental health
Mental ill-health and neurodegenerative conditions such as 
depression, dementia and Alzheimer’s disease have recently been 
integrated into the WHO response to NCDs as a priority disease 
group 129/. Across the EU, over 84.000 people died of mental 
health problems in 2015, while the costs of mental ill-health are 
estimated at €600 billion or 4% of GDP annually 130/. Mental distress 
is often considered to be ‘comorbid’ with other chronic diseases: 
almost every second person with psychological challenges also 
develops chronic physical conditions. Recent studies show that 
the care of individuals with simultaneous physical and mental 
health issues cost healthcare providers 45% more than treating 
patients with the physical illness alone. 131/ Caring responsibilities 
can also have an impact on physical and mental health, particu-
larly if carers do not receive adequate support. 132/
For mental health to be appropriately addressed in any health 
framework, it must have parity of esteem with physical health 
and be dealt with through a comprehensive bio-psychosocial 
approach which is not considered in isolation from physical 
health. The future EU Strategic Framework for the Prevention 
of NCDs should tackle the mental health aspects of NCDs 
in an inclusive and integrated way, while taking a life course 
perspective. It should acknowledge current shifts in mental 
healthcare including those towards the recovery model and 
the move towards the provision of peer support and a range of 
interventions, which are not limited to the provision of psychiatric 
medications, but also include psychosocial services. 133/
E. Adopt a rights-based approach
The Constitution of the WHO declares that “the enjoyment of 
the highest attainable standard of health is one of the funda-
mental rights of every human being” 122/. Several international 
human rights conventions, notably the International Covenant 
on Economic, Social and Cultural Rights 123/ and the Convention 
on the Rights of the Child 124/, lay down legally binding obligations 
on states to uphold human rights relevant to NCD prevention, 
not least the fundamental right to the enjoyment of the highest 
attainable standard of health (the right to health), the right to an 
adequate standard of living, the right to food and the right to a 
clean environment 125/.  
Human rights create entitlements for individuals and obliga-
tions for states to respect, protect, and fulfil these rights 126/. A 
rights-based approach aims to strengthen the capacities of right-
holders – people – to realise their rights, and that of duty-bearers 
– states – to meet their legally binding obligations 127/ 128/. A 
human rights approach offers a robust rationale for action, 
based on fundamental and inalienable human values, rather 
than temporal policy priorities. It also encourages the creation 
of a strong accountability framework for government action. The 
future EU Strategic Framework for the Prevention of NCDs should 
therefore work towards implementing a rights-based approach 
to NCD prevention.
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Action 1: Support the implementation 
of WHO ‘Best Buys’
The WHO “Best Buys and other recommended interventions” are a 
collection of best-practice policies to tackle key NCD risk factors, 
featuring measures on price, advertising, labelling, availability 
and awareness raising 134/. The future EU Strategic Framework for 
the Prevention of NCDs should promote the appropriate imple-
mentation of ‘best buys’ policies, both in terms of ambition – to 
ensure policy design is proportionate to the issue at stake and 
effective for reaching desired aims, and level of implementation 
– either at national or EU level.
In terms of national implementation, the European Commission 
should, with the core participation of the WHO Regional Office 
for Europe, compile, and where relevant adapt for the EU context, 
a set of technical toolkits laying-out the various options linked to 
the implementation of ‘best buys’ policies in Member States 135/. 
These toolkits should also include considerations on ways to 
communicate these measures to maximise public support, 
and on ways to minimise and deflect potential opposition from 
vested interests.
In terms of EU implementation, it should be more explicitly 
acknowledged that EU regulation can be a powerful tool for 
promoting health and well-being for large numbers of people 
at the same time. It can also establish a level playing field for 
businesses within the internal market, allowing the pursuit of 
‘pro-health’ competition and the flourishing of new business 
models. The European Commission should periodically analyse 
gaps in NCD policy at the EU level and initiate legislative proce-
dures where needed, possible and appropriate. It should also 
carry out a risk assessment across EU institutions on the occur-
Bearing in mind the significant powers the EU has to promote a 
high level of public health and referring to the European Commis-
sion’s right of initiative and its role as guardian of the EU Treaties, 
this document proposes a number of concrete actions that 
should form the backbone of the future EU Strategic Framework 
for the Prevention of NCDs. 
The actions referred to below can be organised under two broad 
themes, namely to enable and facilitate the implementation of 
adequate measures for the prevention of NCDs at both national 
and EU levels, and to seek synergies and coherence with other 
policy areas to reap the added value of linking the NCD prevention 
agenda with other societal agendas where co-benefits can be 
achieved.
Enable and facilitate action to tackle NCDs:
 > Action 1: Support the implementation of WHO ‘Best Buys’
 > Action 2: Conduct a ‘health check’ study to identify EU 
barriers to the implementation of national NCD prevention 
policies
 > Action 3: Design EU financial instruments to support national 
investment in prevention programmes and measures
 > Action 4: Elaborate a pan-European system for data 
collection, policy evaluation and accountability
Establish synergies with other policy areas:
 > Action 5: Ensure inter-institutional coordination on health and 
well-being and a policy home for health within the European 
Commission structure
 > Action 6: Launch a ‘Health in All Policies’ online policy portal
 > Action 7:  Pursue ‘EU flagship initiatives’ in areas that can 
deliver co-benefits for NCD prevention and other SDGs
rence of conflicts of interest in policy-making and propose an 
action plan with rectifying measures to prevent undue influence 
by vested interests.
In parallel to addressing implementation, the European 
Commission should work with Member States and the WHO 
Regional Office for Europe to elaborate a set of ‘impact indicators’ 
that Member States can use to support progress monitoring and 
evaluation. The entire set of activities related to promoting the 
implementation of ‘best buys’ deserves to become the leading 
priority for the EU Steering Group on Health Promotion, Disease 
Prevention and Management of Non-Communicable Diseases.
Deliverables:
• A set of technical toolkits setting out different design options 
for the national implementation of each of the policy measures 
included in the WHO ‘best buys’, tailored to the EU context.
• A list of ‘impact indicators’ that Member States can use to 
support progress monitoring.
• A mechanism for periodically analysing gaps in NCD policy 
at EU level and initiating legislative procedures where needed, 
possible and appropriate.
• A risk assessment on the occurrence of conflicts of interest 
across EU institutions and an action plan with measures to 
prevent undue influence by vested interests over policy-
making processes. 
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countries; the process would be specifically aimed to explore 
funding and new financial schemes to support Member States 
invest in prevention. 
Deliverables:
• A cross-sectoral expert group on Financing for Health, which 
will assess and propose different options to enhance societal 
returns on investment by increasing programmes to fund NCD 
prevention.
Action 4:  Elaborate a pan-European 
system for data collection, policy 
evaluation and accountability
Although significant efforts are made to collect health data in 
the EU 137/, the existing gaps in the availability of relevant and 
comparable data remains a barrier to assessing the full implica-
tions of NCDs for individuals, communities, healthcare systems 
and economies. The lack of data prevents researchers and 
governments from assessing the impact and effectiveness of 
NCD policies, programmes and treatment on different population 
groups. Also, data on health proxies, such as trends in risk 
factors like consumption levels of various products, is often 
not available in sufficient detail in a standard, comparable and 
accessible format. 
The European Commission, drawing on expert advice, should 
identify gaps in existing data and data collection methods, 
financially support data collection and host an EU-wide health 
data system with registries for NCD incidence, prevalence, health 
outcomes, costs and key indicators on risk factors. The option to 
ensure accessibility to industry sales data for research purposes 
should be considered as a low-cost option to improve data avail-
ability. In synergy with the establishment of such healthy data 
system, effort should be made to elaborate new policy evaluation 
tools, such as complex and system evaluation methodologies, in 
order to assist researchers and governments in better evaluating 
what policies and actions work and why, and especially to better 
assess the combined effects of multiple interventions 138/.
As a further step, a process of ‘shadow reporting’ should be 
established where civil society organisations are invited to 
provide their assessment of the progress made towards NCD-re-
lated commitments across the EU. Such shadow reporting will 
contribute to a more multifaceted understanding of the progress 
made towards fulfilling commitments and ensure enhanced 
accountability. It may also serve as an additional source of infor-
mation and highlight further gaps in data and knowledge. 
Action 2: Conduct a ‘health check’ 
study to identify EU barriers to 
the implementation of national 
NCD prevention policies
There may be instances where EU legislation, particularly EU 
internal market law, can limit or reduce the scope for Member 
States to introduce health promotion and NCD prevention 
measures. Under the future EU Strategic Framework for the 
Prevention of NCDs the European Commission, including the 
Secretariat-General and the Legal Service, should undertake a 
comprehensive legal analysis to establish an EU inventory of 
legislative barriers to the implementation of prevention policies 
at national and local levels.
Based on this inventory, which should also provide a review of 
potential barriers resulting from international law, an action plan 
should be drawn-up to alleviate the identified barriers and, in 
cases where there is an inherent tension between different objec-
tives contained in the EU Treaties, propose guidance to Member 
States for designing policies in a way to enhance their quality and 
chance to be upheld under legal scrutiny.  
Deliverables:
• A comprehensive legal ‘health check’ inventory of EU and 
international barriers to the implementation of effective NCD 
prevention policies at national and local levels.
• An action plan to alleviate these barriers or guidance for 
designing national NCD prevention policies in a way to 
enhance their chance to be upheld under legal scrutiny.
Action 3:  Design EU financial 
instruments to support national 
investment in prevention 
programmes and measures
Recognising the excellent rates of return on investment of 
public health measures, a process should be initiated under the 
future EU Strategic Framework for the Prevention of NCDs to 
design innovative financial support instruments and incentives 
to overcome the current barriers to investing in prevention. The 
European Commission should convene expertise, including from 
the European Investment Bank and World Bank, as well as other 
relevant organisations to identify barriers and explore tools to 
unleash additional investment in prevention. 
This process, which could draw on the High-Level Expert Group 
on Sustainable Finance 136/, should also explore options under the 
European Semester process, such as increasing opportunities 
for national investments in prevention measures and health 
systems, and improving possibilities under the Structural and 
Cohesion funds to finance public health programmes. 
This process should be closely linked to the work of the EU 
Steering Group on Health Promotion, Disease Prevention and 
Management of Non-Communicable Diseases and synergies 
be ensured. However, while the activities of the Steering Group 
focus on the exchange of experiences, policies and practices 
to prevent, manage and control chronic diseases and facilitate 
the implementation of evidence-based best practices by EU 
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Action 6: Launch a ‘Health in All 
Policies’ online policy portal
Health in All Policies (HiAP) is an approach to policy-making that 
systematically takes into account the health and health-system 
implications of decisions, seeks synergies, and avoids harmful 
health impacts in order to improve population health and health 
equity 141/. The obligation to mainstream a high level of human 
health protection in all policies, effectively the HiAP approach, 
is an integral part of the EU’s mandate. Based on the founding 
Treaties, the EU is obliged to ensure “a high level of human health 
protection” in the “definition and implementation of all Union 
policies and activities” 142/.
The future EU Strategic Framework for the Prevention of NCDs 
needs to renew and strengthen commitment to HiAP. To opera-
tionalise this commitment an online portal should be launched 
introducing several strategic tools for the benefit of policy-
makers, researchers and civil society. In particular, this portal 
should provide an overview of ongoing health-relevant policy 
files, promote improved impact assessment methodologies and 
practices, and ensure compliance after EU policies are adopted. 
The ‘Health in All Policies’ online portal should contain at least 
the following components:
1. A tracking tool providing an overview of all ongoing EU-level 
policy initiatives with potentially significant impacts on health 
and well-being, in particular NCDs. The tool should cover both 
health-specific policies and policies from other domains affecting 
health, such as international trade, agriculture, environment, 
consumer protection, digital, development, internal market, 
industry and so forth;
2. An online directory where all impact assessments conducted 
for the policy initiatives identified in the first point are gathered 
and published. This directory should also contain guidance 
documents on conducting health impact assessment, which 
should be subject to regular methodological updates 143/. This 
directory should furthermore provide an interface with academic 
researchers and health organisations allowing them to comment 
on the conducted health impact assessments so as to ensure a 
continuous improvement in their methodologies. 
3. A tool to track the implementation status and impact of 
finalised policy files. This tool should allow the European 
Commission to step-up its role as guardian of the EU Treaties 
by providing a clearer overview of potential bottlenecks in 
national implementation and enforcement, and allowing it to 
take the necessary steps to redress deficiencies, including, when 
necessary, infringement procedures. The tool should contain 
a mechanism for civil society organisations to report issues 
related to national implementation. In this way creating a hub for 
cross-border learning and expanding the evidence-base about 
which measures work and why. It could have a special focus on 
policies with a strong impact on children and youth, to ensure 
the future generation throughout the EU is equally protected and 
empowered from their early age onward.
Deliverables:
• A ‘Health in All Policies’ online policy portal, which should:
 > Present an overview of ongoing, health relevant initiatives 
in all policy areas 
 > Publish the results of all health impact assessments and 
provide the opportunity for continuous improvements in 
methodology;
Regarding research funding, the European Commission should 
undertake an evaluation to investigate which programmes and 
projects brought the highest gains in terms of disease prevention. 
The evaluation should highlight areas where research has been 
duplicated, so as to avoid future double-funding of the same 
research questions. Conclusions should be drawn, and indicators 
proposed on how to define future research needs to tackle major 
societal challenges, such as NCD prevention. The conclusions 
and indicators should address how to ensure better uptake of 
research outcomes to inform policy decision-making both at the 
EU and national level. The conclusions should consider the use 
of ‘ex-ante conditionalities’ (conditions which must be met in 
order to access funds) in the area of health-relevant projects and 
funding, as appropriate.  139/
Deliverables:
• An EU-wide system for health data collection and information 
sharing containing registries for key NCD indicators.
• An extensive study putting forward methodologies for new 
health policy evaluation tools.
• A process of ‘shadow reporting’ where civil society can 
contribute with their assessments on the progress made 
towards fulfilling NCD-related commitments.
• An assessment of how health systems can better address 
primary prevention.
• An evaluation of the added value of past research funding and 
possible a proposal for ex-ante conditionalities in the area of 
health-relevant projects and funding.
Action 5: Ensure institutional 
coordination on health and well-being 
and a policy home for health within 
the European Commission structure 
Considering the strong interconnections between the NCD 
prevention agenda and other policy areas, adequate institutional 
alignment needs to be ensured. Fully operationalising the future 
EU Strategic Framework for the Prevention of NCDs therefore 
requires a new coordination mandate high-up in the EU institu-
tional structure, such as the position of a European Commission 
vice-president. 
This role should ensure inter- and intra-institutional coordination, 
and create co-ownership of cross-cutting policy files between 
public health and other areas 140/. To ensure a strong basis for 
action a dedicated health directorate should be maintained as 
part of the European Commission structure.
Deliverables:
• A new EU high-level coordination mandate, such as a European 
Commission vice-president, that will ensure inter- and intra-in-
stitutional policy coordination for health and well-being.
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 > Monitor national implementation of health-related 
policies to promote better compliance with EU health-re-
lated policies.
• An updated methodology for health impact assessment and a 
process for regular updates to the methodology. 
• An analysis of compliance with a select number of key policy 
files, in particular those related to the national implementation 
of policies focused on children and youth.
Action 7:  Pursue ‘EU flagship initiatives’ 
in areas that can deliver co-benefits 
for NCD prevention and other SDGs 
NCDs frequently share both drivers and solutions with other 
major societal challenges. This offers significant opportunities 
to achieve positive, cross-sectoral synergies (or ‘co-benefits’), 
described as the “additional benefits of tackling multiple issues 
simultaneously” 144/.  
A process should be established under the future EU Strategic 
Framework for the Prevention of NCDs to define areas where 
policy synergies can be achieved between NCD prevention 
and other policy areas, and to elaborate action plans for ‘EU 
flagship initiatives’ that spell-out policy pathways to maximise 
co-benefits. This process should be based on consultations 
with relevant experts and organisations with due attention to 
managing potential conflicts of interest. Apart from maximising 
efficiency in the use of policy resources, flagship initiatives will 
help communicate the EU’s pursuit of a positive public goods 
agenda for Europeans.
A number of areas where co-benefits can be achieved:
 > Advancing universal health coverage to improve NCD 
prevention, tackle health inequalities and contribute to social 
justice
 > Transitioning towards healthy diets from sustainable food 
systems, allowing to tackle diet-related NCDs, climate change 
and other drivers of environmental and health harm, while 
building a future-proof European agri-food sector 145/
 > Reshaping the marketing environment to ensure children and 
youth can safely navigate communications channels without 
exposure to the marketing of health-harming products and 
services, while creating a level playing field for business in 
Europe
 > Redesigning urban mobility infrastructures and public spaces 
to tackle air quality and climate change, while simultaneously 
creating physical activity-friendly environments
 > Moving towards a toxic-free circular economy to maximise 
resource use efficiency and reduce the risk of exposure 
to hazardous chemicals, while improving the long-term 
competitiveness of EU industry
 > Ensuring increased government revenues while reducing NCD 
prevalence and health inequalities through effective taxation 
policies 146/.
Deliverables:
• A series of action plans to pursue EU ‘flagship initiatives’ in 
areas where clear co-benefits can be achieved between NCD 
prevention and other policy areas.
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